The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis

New oral anticoagulants (NOACs; ie, direct thrombin inhibitor [DTI] and factor Xa [FXa] inhibitors) were used as alternatives to warfarin. Specific antidotes (idarucizumab for dabigatran and andexanet alfa for FXa inhibitors) and hemostatic reversal agents were used for lowering bleeding, but their...

Descripción completa

Detalles Bibliográficos
Autores principales: Udayachalerm, Sariya, Rattanasiri, Sasivimol, Angkananard, Teeranan, Attia, John, Sansanayudh, Nakarin, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714855/
https://www.ncbi.nlm.nih.gov/pubmed/30176738
http://dx.doi.org/10.1177/1076029618796339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714855/
https://www.ncbi.nlm.nih.gov/pubmed/30176738
http://dx.doi.org/10.1177/1076029618796339

Ejemplares similares